S ometimes, the main source of tension in an anime is the tumultuous relationship between the main protagonist and antagonist ...
BNP PARIBAS ASSET MANAGEMENT Holding S.A. acquired a new stake in Protagonist Therapeutics, Inc. (NASDAQ:PTGX – Free Report) ...
Inc. ("Protagonist" or the "Company") today announced the selection of PN-881, a potential best-in-class oral peptide interleukin-17 (IL-17) antagonist, as a development candidate for the ...
Inc. ("Protagonist" or the "Company") today announced that the company will host a conference call and webcast to announce its oral peptide IL-17 antagonist development candidate and to share in ...